Earnings call transcript: Angel beats Q3 2026 estimates as growth accelerates Investing.com · News 5m ago
Earnings call transcript: Caesarstone posts Q3 2026 loss but narrows deficit Investing.com · News 8m ago
Jefferies reiterates Acrivon Therapeutics stock rating on drug development path Investing.com · News 11m ago
Velaris at Stifel 2026 Healthcare Conference: betting on next-gen activin drugs Investing.com · News 16m ago
Sutro Biopharma at Stifel 2026 Healthcare Conference 2026: platform push Investing.com · News 17m ago
Tata Power Q2 FY27 slides: record profit, clean energy expansion accelerates Investing.com · News 17m ago